Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-1-20
pubmed:abstractText
Large-conductance, calcium- and voltage-activated potassium (BK(Ca)) channels hyperpolarize coronary artery smooth muscle cells, causing vasorelaxation. Dopamine activates BK(Ca) channels by stimulating D(1)-like receptor-mediated increases in cAMP in porcine coronary artery myocytes. There are two D(1)-like receptors (R), D(1)R and D(5)R. We hypothesize that the specific D(1)-like receptor involved in BK(Ca) channel activation in human coronary artery smooth muscle cells (HCASMCs) is the D(5)R and that activation occurs via cAMP cross-activation of cGMP-dependent protein kinase (PKG), rather than cAMP-dependent protein kinase (PKA). The effects of D(1)-like receptor agonists and antagonists on BK(Ca) channel opening in HCASMCs were examined in the presence and absence of PKG/PKA inhibition by cell-attached patch clamp. In the absence of commercially available ligands specific for D(1)R or D(5)R, D(1)R or D(5)R protein was down-regulated by transfecting HCASMCs with human D(1)R or D(5)R antisense oligonucleotides, respectively: cells transfected with scrambled oligonucleotides and nontransfected HCASMCs served as controls. The predominant ion channel conducting outward currents in nontransfected HCASMCs was identified as the large-conductance, calcium- and voltage-activated potassium (BK(Ca)) channel, which was activated by D(1)-like receptor agonists despite PKA inhibition with (9R,10S,12S)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid (KT 5720) (300 nM), but was abolished by inhibiting PKG with 9-methoxy-9-methoxycarbonyl-8-methyl-2,3,9,10-tetrahydro-8,11-epoxy-1H,8H,11H-2,7b-11a-triazadibenzo(a,g) cycloocta(cde)-trinden-1-one (KT 5823) (300 nM). D(1)-like receptor agonists activated BK(Ca) channels in all transfected cells except those transfected with D(5)R antisense oligonucleotides. Thus, the dopamine (D(1)-like) receptor mediates activation of BK(Ca) channels in HCASMCs by D(5)R, not D(1)R, and via PKG, not PKA. This is the first report of differential D(1)-like receptor regulation of vascular smooth muscle function in human cells.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-10087453, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-10205244, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-10547076, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-10642294, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-10785513, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-10803733, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-11031203, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-11057658, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-11306529, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-11583807, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-11861036, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-12010185, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-12437142, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-12547730, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-12563019, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-12566973, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-12623966, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-15569306, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-1561715, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-15968424, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-16313517, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-17459951, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-18172057, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-18287888, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-18562499, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-19047479, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-2566608, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-6294539, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-7554147, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-7733230, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-8338137, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-8381602, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-8584979, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-8635225, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-8702641, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-9016340, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-9087677, http://linkedlifedata.com/resource/pubmed/commentcorrection/19864616-9323013
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1521-0103
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
332
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
640-9
pubmed:dateRevised
2011-7-22
pubmed:meshHeading
More...